Mkts

Ironwood Pharmaceuticals, Inc.

NASDAQ: IRWD
$4.70-0.01 (-0.21%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
4.644.87
52-week range
2.955.78
Today
Open4.66
Previous close4.70
Volume2.04M
Valuation
Market cap779.74M
P/E ratio6.00×
EPS (TTM)0.76
Income & risk
Dividend / yield—
Beta0.06
Avg volume2.09M
Discussion

IRWD News

Stories mentioning IRWD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue106,50647,709122,06085,23941,14390,54591,59294,396
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development21,94021,86322,46823,37327,43225,39129,82730,388
Sales General & Admin12,03319,29321,90816,79524,26033,59036,11336,964
Total Operating Expenses
Operating Income (Loss)72,5736,80575,48445,321(29,108)31,49125,63624,977
Interest Income
Interest Expense
Other Expense42.0077.0040.0039.0037.00
Pretax Income65,172455.0068,02037,822(36,272)23,99517,36918,876
Tax Provision24,3992,73127,94014,2231,11421,73913,72319,736
Net Income (Loss)40,773(2,276)40,08023,599(37,386)2,2563,646(860.00)
Earnings Per Share (Basic)0.25(0.01)0.250.15(0.23)0.010.02(0.01)
Earnings Per Share (Diluted)0.24(0.01)0.230.14(0.23)0.010.02(0.01)
Weighted Average Shares Outstanding (Basic)163,451161,842162,215161,723160,974159,083159,706159,014
Weighted Average Shares Outstanding (Diluted)166,690162,983177,764176,837160,974160,084160,232159,014

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About IRWD

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is a stock listed on the Nasdaq Stock Market under the ticker symbol IRWD. It last traded at $4.70 (Nov 20, 2026, 4:00 PM ET), down 0.2% on the day. That gives Ironwood Pharmaceuticals a market capitalisation of $779.7M and a price-to-earnings ratio of 6.0.

Over the past 52 weeks IRWD has traded between $2.95 and $5.78.

Revenue for the quarter ended Mar 31, 2026 was $106.5M; net income $40.8M. Revenue was up 159% from $41.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$106.5M$40.8M38.3%
Dec 31, 2025$47.7M-$2.3M-4.8%
Sep 30, 2025$122.1M$40.1M32.8%
Jun 30, 2025$85.2M$23.6M27.7%

From Ironwood Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…